The Study of the Impact of Disclosing Imaging Study Information to Trial Participants

Completed

Conditions studied: Parkinsonian Syndrome, Parkinson

In brief

The overall goal of the study is to evaluate how research participants in Parkinson Disease studies that include brain imaging with a dopamine transporter ligand choose to receive the imaging data and what is the impact of the imaging data information on the management of their symptoms.

Key facts

Study ID

NCT00354003

Run by

Institute for Neurodegenerative Disorders

People needed

800

Starts

2006-07-01

Expected to finish

2008-08-01

Last updated by the study team

2019-04-03

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Previous participation in imaging study as described within the protocol

Where it is running

• Institute for Neurodegenerative Disorders — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.